TAZ Antikörper (C-Term)
-
- Target Alle TAZ Antikörper anzeigen
- TAZ (Tafazzin (TAZ))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser TAZ Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Marke
- IHC-plus™
- Spezifität
- Human TAZ
- Aufreinigung
- Immunoaffinity purified
- Immunogen
-
Synthetic peptide corresponding to a region within amino acids 226 and 292 of TAZ (SwissProt Q16635). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Synthetic peptide - Isotyp
- IgG
- Top Product
- Discover our top product TAZ Primärantikörper
-
-
- Applikationshinweise
-
Approved: ELISA, IHC, IHC-P (10 μg/mL)
Usage: Antibody reactive against peptide, detects immunogen. - Kommentare
-
Target Species of Antibody: Human
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- Lot specific
- Buffer
- PBS, pH 7, 10 % Glycerol, 0.01 % Thimerosal
- Konservierungsmittel
- Thimerosal (Merthiolate)
- Vorsichtsmaßnahmen
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and freeze at -20°C. Avoid freeze-thaw cycles.
-
- Target
- TAZ (Tafazzin (TAZ))
- Andere Bezeichnung
- TAZ (TAZ Produkte)
- Hintergrund
-
Name/Gene ID: TAZ
Synonyms: TAZ, BTHS, EFE, Endocardial fibroelastosis 2, EFE2, LVNCX, Protein G4.5, Tafazzin, CMD3A, G4.5, TAZ1, XAP-2 - Gen-ID
- 6901
- UniProt
- Q16635
-